Cellect Biotechnology Ltd (APOP)

14.470
-0.480(-3.21%)
After Hours
14.460
-0.010(-0.069%)
- Real-time Data
  • Volume:
    61,803
  • Bid/Ask:
    14.020/15.300
  • Day's Range:
    14.420 - 15.570

APOP Overview

Prev. Close
14.95
Day's Range
14.42-15.57
Revenue
-
Open
14.75
52 wk Range
6.598-35.52
EPS
-
Volume
61,803
Market Cap
14.19M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
598,107
P/E Ratio
-
Beta
-
1-Year Change
68.26%
Shares Outstanding
980,434
Next Earnings Date
24 Nov 2021
What is your sentiment on Cellect Biotechnology Ltd?
or
Market is currently closed. Voting is open during market hours.

Cellect Biotechnology Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Cellect Biotechnology Ltd Company Profile

Cellect Biotechnology Ltd Company Profile

Cellect Biotechnology Ltd is an Israel-based biotechnology company. Its technology platform, ApoGraft, selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies by using functional selection. Efficient selection enables retention of most of the stem cells while neutralizing harmful mature cells. ApoGraft exploit a functional characteristic of stem cells relating to apoptosis, which is the process of programmed cell death and is a vital part of physiological development and homeostasis of all organisms. Stem cells flourish in an environment where normal cells die because their main role is reconstitution of damaged tissue. The platform is being tested for clinical use in allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of hematological malignancies. Additionally, the Company is developing its first product based on its platform, the ApoTainer selection kit that utilizes FasL-coated paramagnetic beads.

Read More
  • bitcoin mujhe iPhone 12 pro Max chahiye
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.